BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
The combination of wheat peptides and fucoidan protects against chronic superficial gastritis and alters gut microbiota: a double-blinded, placebo-controlled study. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: 59 Issue 4 Pages: 1655-1666 Pub: 2020 Jun Epub: 2019 Jun 22 Authors Kan J , Cheng J , Xu L , Hood M , Zhong D , Cheng M , Liu Y , Chen L , Du J , |
|
|
Therapeutic Potential of Fucoidan in Alleviating Histamine-Induced Liver Injury: Insights from Mice Studies. ✅
Go to Publication ✅
Foods (Basel, Switzerland) (Foods ) Vol: 13 Issue 10 Pages: Pub: 2024 May 14 Epub: 2024 May 14 Authors Zhang M , Liu H , Xu L , Zhang X , Chen W , Wang C , |
|
|
Fucoidan enhances the anti-tumor effect of anti-PD-1 immunotherapy by regulating gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 7 Pages: 3463-3478 Pub: 2024 Apr 2 Epub: 2024 Apr 2 Authors Li H , Dong T , Tao M , Zhao H , Lan T , Yan S , Gong X , Hou Q , Ma X , Song Y , |
|
|
Scytosiphon lomentaria fucoidan ameliorates DSS-induced colitis in dietary fiber-deficient mice via modulating the gut microbiota and inhibiting the TLR4/NF-?B/MLCK pathway. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 253 Issue Pt 8 Pages: 127337 Pub: 2023 Dec 31 Epub: 2023 Oct 31 Authors Jia J , Zheng W , Tang S , Song S , Ai C , |
|
|
Marine prebiotics mediate decolonization of Pseudomonas aeruginosa from gut by inhibiting secreted virulence factor interactions with mucins and enriching Bacteroides population. ✅
Go to Publication ✅
Journal of biomedical science (J Biomed Sci ) Vol: 30 Issue 1 Pages: 9 Pub: 2023 Feb 2 Epub: 2023 Feb 2 Authors Janapatla RP , Dudek A , Chen CL , Chuang CH , Chien KY , Feng Y , Yeh YM , Wang YH , Chang HJ , Lee YC , Chiu CH , |
|
|
Fucoidan from Scytosiphon lomentaria protects against destruction of intestinal barrier, inflammation and lipid abnormality by modulating the gut microbiota in dietary fibers-deficient mice. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 224 Issue Pages: 556-567 Pub: 2023 Jan 1 Epub: 2022 Oct 19 Authors Jia J , Zheng W , Zhang C , Zhang P , Guo X , Song S , Ai C , |
|
|
Saccharina japonica fucan suppresses high fat diet-induced obesity and enriches fucoidan-degrading gut bacteria. ✅
Go to Publication ✅
Carbohydrate polymers (Carbohydr Polym ) Vol: 290 Issue Pages: 119411 Pub: 2022 Aug 15 Epub: 2022 Apr 8 Authors Wei B , Zhang B , Du AQ , Zhou ZY , Lu DZ , Zhu ZH , Ke SZ , Wang SJ , Yu YL , Chen JW , Zhang HW , Jin WH , Wang H , |
|
|
Sargassum fusiforme fucoidan modifies gut microbiota and intestinal metabolites during alleviation of hyperglycemia in type 2 diabetic mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 8 Pages: 3572-3585 Pub: 2021 Apr 26 Epub: Authors Wu Q , Wu S , Cheng Y , Zhang Z , Mao G , Li S , Yang Y , Zhang X , Wu M , Tong H , |
|
|
Modulation of Gene Expression in a Sterile Atopic Dermatitis Model and Inhibition of Staphylococcus aureus Adhesion by Fucoidan. ✅
Go to Publication ✅
Dermatopathology (Basel, Switzerland) (Dermatopathology (Basel) ) Vol: 8 Issue 2 Pages: 69-83 Pub: 2021 Mar 25 Epub: 2021 Mar 25 Authors Park AY , Bourtembourg M , Chrétien A , Hubaux R , Lancelot C , Salmon M , Fitton JH , |
|
|
Fucoidan from Undaria pinnatifida Enhances Exercise Performance and Increases the Abundance of Beneficial Gut Bacteria in Mice. ✅
Go to Publication ✅
Marine drugs (Mar Drugs ) Vol: 22 Issue 11 Pages: Pub: 2024 Oct 29 Epub: 2024 Oct 29 Authors Yang C , Dwan C , Wimmer BC , Wilson R , Johnson L , Caruso V , |
|
|
Low molecular fucoidan alleviated alcohol-induced liver injury in BALB/c mice by regulating the gut microbiota-bile acid-liver axis. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 282 Issue Pt 3 Pages: 136930 Pub: 2024 Dec Epub: 2024 Oct 28 Authors Sun Y , Men Q , Ren X , Yan C , Song S , Ai C , |
|
|
Low molecular fucoidan alleviated alcohol-induced liver injury in BALB/c mice by regulating the gut microbiota-bile acid-liver axis. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 282 Issue Pt 3 Pages: 136930 Pub: 2024 Dec Epub: 2024 Oct 28 Authors Sun Y , Men Q , Ren X , Yan C , Song S , Ai C , |
|
|
Antimicrobial, antidiabetic, antiviral, and antioxidant activities of fucoidan extracted from the brown seaweed Padina pavonica. ✅
Go to Publication ✅
BMC biotechnology (BMC Biotechnol ) Vol: 25 Issue 1 Pages: 70 Pub: 2025 Jul 9 Epub: 2025 Jul 9 Authors Akl FMA , El-Sheekh MM , Makhlof MEM , Ahmed SI , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
